Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Testicular, Ovarian, Bladder, Lung, Colorectal, Gastric, and Head & Neck Cancers.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.
Approved for use in oncology care according to FDA-approved indications.
Targeted treatment of solid tumors and hematologic malignancies.
Approved for use in oncology care according to FDA-approved indications.